Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar pchop123 (79.79) Submitted: 7/12/2013 1:55:37 PM : Outperform Start Price: $2.68 CYTX Score: -3.88

timely

Featured Broker Partners


Advertisement